Key facts
- It has raised $200K; the latest was Later Stage VC ($200K) in Apr 2025.
- Notable investors include Aesculap USA, The University of Freiburg.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Neuroloop
- ·The full record, as it builds
Funding rounds
No funding rounds for Neuroloop are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Neuroloop
Developer of a closed-loop implantable device designed to be used in the field of functional neurosurgery. The company has developed an innovative technology that uses cuff electrodes to help selective stimulation of fibers in the vagus nerve, enabling patients suffering from nerve disorders to get an effective and instantaneous cure.
- Sector
- Healthcare
- HQ
- Freiburg, Germany
- Founded
- 2015
- Employees
- 40
- Website
- neuroloop.de/
- Ownership
- Privately Held (backing)
Neuroloop doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Neuroloop shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Neuroloop in its N-PORT filings yet. We sweep new filings monthly.